Business Paid
Molecure denied approval for Sarcoidosis drug trial in the EU
18:38
Molecure has been denied permission to conduct Phase II clinical trials for the molecule OATD-01 in patients with active pulmonary sarcoidosis in the European Union and Norway.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
